Lin JK; Tsai SH
Chemoprevention of cancer and cardiovascular disease by resveratrol.
Proc Natl Sci Counc Repub China B 1999 Jul;23(3):99-106

Sprong RC; Winkelhuyzen-Janssen AM; Aarsman CJ; van Oirschot JF; et al 
Low-dose N-acetylcysteine protects rats against endotoxin-
mediated oxidative stress, but high-dose increases mortality.
Am J Respir Crit Care Med 1998 Apr;157(4 Pt 1):1283-93

Sappey C; Boelaert JR; Legrand-Poels S; Forceille C; and others
Iron chelation decreases NF-kappa B and HIV type 1 activation 
due to oxidative stress.
AIDS Res Hum Retroviruses 1995 Sep;11(9):1049-61

Suzuki YJ; Packer L
Redox regulation of DNA-protein interactions by biothiols.
Methods Enzymol 1995;252:175-80

Staal FJ; Anderson MT; Herzenberg LA
Redox regulation of activation of NF-kappa B transcription 
factor complex: effects of N-acetylcysteine.
Methods Enzymol 1995;252:168-74

Schulze-Osthoff K; Los M; Baeuerle PA
Redox signalling by transcription factors NF-kappa B and AP-1 
in lymphocytes.      REVIEW ARTICLE: 69 REFS.
Biochem Pharmacol 1995 Sep 7;50(6):735-41

Anderson MT; Staal FJ; Gitler C; Herzenberg LA; Herzenberg LA
Separation of oxidant-initiated and redox-regulated steps in the NF-
kappa B signal transduction pathway.
Proc Natl Acad Sci U S A 1994 Nov 22;91(24):11527-31

Suzuki YJ; Mizuno M; Tritschler HJ; Packer L
Redox regulation of NF-kappa B DNA binding activity by dihydrolipoate.
Biochem Mol Biol Int 1995 Jun;36(2):241-6

Yang JP; Merin JP; Nakano T; Kato T; and others
Inhibition of the DNA-binding activity of NF-kappa B by 
gold compounds in vitro.
FEBS Lett 1995 Mar 13;361(1):89-96

Sappey C; Legrand-Poels S; Best-Belpomme M; Favier A; and others
Stimulation of glutathione peroxidase activity decreases 
HIV type 1 activation after oxidative stress.
AIDS Res Hum Retroviruses 1994 Nov;10(11):1451-61

Hennig B; Diana JN; Toborek M; McClain CJ
Influence of nutrients and cytokines on endothelial cell metabolism.
REVIEW ARTICLE: 73 REFS.
J Am Coll Nutr 1994 Jun;13(3):224-31

Mitomo K; Nakayama K; Fujimoto K; Sun X; and others
Two different cellular redox systems regulate the DNA-binding 
activity of the p50 subunit of NF-kappa B in vitro.
Gene 1994 Aug 5;145(2):197-203

Blake DR; Winyard PG; Marok R
The contribution of hypoxia-reperfusion injury to inflammatory 
synovitis: the influence of reactive oxygen intermediates 
on the transcriptional control of inflammation.  REVIEW ARTICLE: 54 REFS.
Ann N Y Acad Sci 1994 Jun 17;723:308-17

Behl C; Davis JB; Lesley R; Schubert D
Hydrogen peroxide mediates amyloid beta protein toxicity.
Cell 1994 Jun 17;77(6):817-27

Mahon TM; Brennan P; O'Neill LA
Evidence for a redox-sensitive protein tyrosine kinase in nuclear factor 
kappa B activation and interleukin 2 production in EL4.NOB1 cells.
Biochem Soc Trans 1993 Nov;21(4):389S

Menon SD; Qin S; Guy GR; Tan YH
Differential induction of nuclear NF-kappa B by protein phosphatase 
inhibitors in primary and transformed human cells. Requirement for 
both oxidation and phosphorylation in nuclear translocation.
J Biol Chem 1993 Dec 15;268(35):26805-12

Hayashi T; Ueno Y; Okamoto T
Oxidoreductive regulation of nuclear factor kappa B. Involvement 
of a cellular reducing catalyst thioredoxin.
J Biol Chem 1993 May 25;268(15):11380-8

Matthews JR; Kaszubska W; Turcatti G; Wells TN; Hay RT
Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B.
Nucleic Acids Res 1993 Apr 25;21(8):1727-34

Toledano MB; Ghosh D; Trinh F; Leonard WJ
N-terminal DNA-binding domains contribute to differential DNA-
binding specificities of NF-kappa B p50 and p65.
Mol Cell Biol 1993 Feb;13(2):852-60

Matthews JR; Wakasugi N; Virelizier JL; Yodoi J; Hay RT
Thioredoxin regulates the DNA binding activity of NF-kappa 
B by reduction of a disulphide bond involving cysteine 62.
Nucleic Acids Res 1992 Aug 11;20(15):3821-30

Molitor JA; Ballard DW; Greene WC
Kappa B-specific DNA binding proteins are differentially 
inhibited by enhancer mutations and biological oxidation.
New Biol 1991 Oct;3(10):987-96

Middleton G; Hamanoue M; Enokido Y; Wyatt S; and others
Cytokine-induced nuclear factor kappa B activation promotes 
the survival of developing neurons [see comments]
J Cell Biol 2000 Jan 24;148(2):325-32
Comment in: J Cell Biol 2000 Jan 24;148(2):223-5

Hill DB; Devalaraja R; Joshi-Barve S; Barve S; McClain CJ
Antioxidants attenuate nuclear factor-kappa B activation and 
tumor necrosis factor-alpha production in alcoholic 
hepatitis patient monocytes and rat Kupffer cells, in vitro.
Clin Biochem 1999 Oct;32(7):563-70

Haridas V; Shrivastava A; Su J; Yu GL; and others
VEGI, a new member of the TNF family activates nuclear factor-
kappa B and c-Jun N-terminal kinase and modulates cell growth.
Oncogene 1999 Nov 11;18(47):6496-504

Yamashita N; Koizumi H; Murata M; Mano K; Ohta K
Nuclear factor kappa B mediates interleukin-8 production in eosinophils.
Int Arch Allergy Immunol 1999 Nov;120(3):230-6

Mizutani A; Tsukagoshi N
Molecular role of ascorbate in enhancement of NO production 
in activated macrophage-like cell line, J774.1.
J Nutr Sci Vitaminol (Tokyo) 1999 Aug;45(4):423-35

Plummer SM; Holloway KA; Manson MM; Munks RJ; and others
Inhibition of cyclo-oxygenase 2 expression in colon cells by the 
chemopreventive agent curcumin involves inhibition of NF-kappa B 
activation via the NIK/IKK signalling complex.
Oncogene 1999 Oct 28;18(44):6013-20

Schwertschlag US; Trepicchio WL; Dykstra KH; Keith JC; and others
Hematopoietic, immunomodulatory and epithelial effects of interleukin-11.
Leukemia 1999 Sep;13(9):1307-15

Hagimoto N; Kuwano K; Kawasaki M; Yoshimi M; and others
Induction of interleukin-8 secretion and apoptosis 
in bronchiolar epithelial cells by Fas ligation.
Am J Respir Cell Mol Biol 1999 Sep;21(3):436-45

Feig BW; Lu X; Hunt KK; Shan Q; and others
Inhibition of the transcription factor nuclear factor-kappa B by adenoviral 
mediated expression of I kappa B alpha M results in tumor cell death.
Surgery 1999 Aug;126(2):399-405

McDade TP; Perugini RA; Vittimberga FJ Jr; Callery MP
Ubiquitin-proteasome inhibition enhances apoptosis 
of human pancreatic cancer cells.
Surgery 1999 Aug;126(2):371-7

Lindros KO; Jokelainen K; Nanji AA
Acetaldehyde prevents nuclear factor-kappa B activation 
and hepatic inflammation in ethanol-fed rats.
Lab Invest 1999 Jul;79(7):799-806

Ichiyama T; Sakai T; Catania A; Barsh GS; and others
Systemically administered alpha-melanocyte-stimulating peptides 
inhibit NF-kappaB activation in experimental brain inflammation.
Brain Res 1999 Jul 31;836(1-2):31-7

Nakashima Y; Sun DH; Trindade MC; Maloney WJ; and others
Signaling pathways for tumor necrosis factor-alpha and interleukin-6 
expression in human macrophages exposed to titanium-alloy 
particulate debris in vitro [see comments]
J Bone Joint Surg Am 1999 May;81(5):603-15
Comment in: J Bone Joint Surg Am 1999 May;81(5):599-602

Vittimberga FJ Jr; McDade TP; Perugini RA; Callery MP
Sodium salicylate inhibits macrophage TNF-alpha production 
and alters MAPK activation.
J Surg Res 1999 Jun 15;84(2):143-9

Selzman CH; Shames BD; McIntyre RC Jr; Banerjee A; Harken AH
The NFkappaB inhibitory peptide, IkappaBalpha, 
prevents human vascular smooth muscle proliferation.
Ann Thorac Surg 1999 May;67(5):1227-31; discussion 1231-2

McDade TP; Perugini RA; Vittimberga FJ Jr; Carrigan RC; Callery MP
Salicylates inhibit NF-kappaB activation and enhance TNF-alpha induced 
apoptosis in human pancreatic cancer cells.
J Surg Res 1999 May 1;83(1):56-61

Saklatvala J; Dean J; Finch A
Protein kinase cascades in intracellular signalling by interleukin-I 
and tumour necrosis factor.
Biochem Soc Symp 1999;64:63-77

Takahashi S; Kapas L; Fang J; Krueger JM
Somnogenic relationships between tumor necrosis factor and interleukin-1. 
Am J Physiol 1999 Apr;276(4 Pt 2):R1132-40

Han Y; Runge MS; Brasier AR
Angiotensin II induces interleukin-6 transcription in vascular smooth 
muscle cells through pleiotropic activation of nuclear factor-kappa B 
transcription factors.
Circ Res 1999 Apr 2;84(6):695-703

Sanchez de Miguel L; de Frutos T; Gonzalez-Fernandez F; 
del Pozo V; and others
Aspirin inhibits inducible nitric oxide synthase expression and 
tumour necrosis factor-alpha release by cultured smooth muscle cells.
Eur J Clin Invest 1999 Feb;29(2):93-9

Faller DV
Endothelial cell responses to hypoxic stress.
Clin Exp Pharmacol Physiol 1999 Jan;26(1):74-84

Ward C; Chilvers ER; Lawson MF; Pryde JG; and others
NF-kappaB activation is a critical regulator 
of human granulocyte apoptosis in vitro.
J Biol Chem 1999 Feb 12;274(7):4309-18

Ping D; Boekhoudt GH; Rogers EM; Boss JM
Nuclear factor-kappa B p65 mediates the assembly and activation of the 
TNF-responsive element of the murine monocyte chemoattractant-1 gene.
J Immunol 1999 Jan 15;162(2):727-34

Sumitomo M; Tachibana M; Nakashima J; Murai M; and others
An essential role for nuclear factor kappa B in preventing TNF-alpha 
induced cell death in prostate cancer cells.
J Urol 1999 Feb;161(2):674-9

Schreiber S
Experimental immunomodulatory therapy of inflammatory bowel disease.
Neth J Med 1998 Dec;53(6):S24-31

Cho S; Urata Y; Iida T; Goto S; and others
Glutathione downregulates the phosphorylation of I kappa B: autoloop 
regulation of the NF-kappa B-mediated expression of NF-kappa B subunits 
by TNF-alpha in mouse vascular endothelial cells.
Biochem Biophys Res Commun 1998 Dec 9;253(1):104-8

Saliou C; Rihn B; Cillard J; Okamoto T; Packer L
Selective inhibition of NF-kappaB activation by the flavonoid hepato-
protector silymarin in HepG2. Evidence for different activating pathways.
FEBS Lett 1998 Nov 27;440(1-2):8-12

Bustos C; Hernandez-Presa MA; Ortego M; Tunon J; and others
HMG-CoA reductase inhibition by atorvastatin reduces neointimal 
inflammation in a rabbit model of atherosclerosis.
J Am Coll Cardiol 1998 Dec;32(7):2057-64

Barnes PJ
Anti-inflammatory actions of glucocorticoids: molecular mechanisms. 
Clin Sci (Colch) 1998 Jun;94(6):557-72

Katsuyama K; Shichiri M; Marumo F; Hirata Y
NO inhibits cytokine-induced iNOS expression and NF-kappaB activation 
by interfering with phosphorylation and degradation of IkappaB-alpha. 
Arterioscler Thromb Vasc Biol 1998 Nov;18(11):1796-802

Thurberg BL; Collins T
The nuclear factor-kappa B/inhibitor of kappa B autoregulatory 
system and atherosclerosis.
Curr Opin Lipidol 1998 Oct;9(5):387-96

Brenner DA
Signal transduction during liver regeneration.
Department of Medicine, University of North Carolina at 
J Gastroenterol Hepatol 1998 Sep;13 Suppl:S93-5

Bond M; Fabunmi RP; Baker AH; Newby AC
Synergistic upregulation of metalloproteinase-9 by growth factors 
and inflammatory cytokines: an absolute requirement 
for transcription factor NF-kappa B.
FEBS Lett 1998 Sep 11;435(1):29-34

Manna SK; Aggarwal BB
IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, 
activation protein-1, and apoptosis.
J Immunol 1998 Sep 15;161(6):2863-72

Wang CY; Mayo MW; Korneluk RG; Goeddel DV; Baldwin AS Jr
NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and 
c-IAP2 to suppress caspase-8 activation.
Science 1998 Sep 11;281(5383):1680-3

Kurokouchi K; Kambe F; Yasukawa K; Izumi R; and others
TNF-alpha increases expression of IL-6 and ICAM-1 genes 
through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells.
J Bone Miner Res 1998 Aug;13(8):1290-9

Peng HB; Spiecker M; Liao JK
Inducible nitric oxide: an autoregulatory feedback inhibitor 
of vascular inflammation.
J Immunol 1998 Aug 15;161(4):1970-6

Jeppson JD; Patel HR; Sakata N; Domenico J; and others
Requirement for dual signals by anti-CD40 and IL-4 for the induction 
of nuclear factor-kappa B, IL-6, and IgE in human B lymphocytes.
J Immunol 1998 Aug 15;161(4):1738-42

Jobin C; Hellerbrand C; Licato LL; Brenner DA; Sartor RB
Mediation by NF-kappa B of cytokine induced expression 
of intercellular adhesion molecule 1 (ICAM-1) in an intestinal 
epithelial cell line, a process blocked by proteasome inhibitors.
Gut 1998 Jun;42(6):779-87

Nemeth ZH; Hasko G; Vizi ES
Pyrrolidine dithiocarbamate augments IL-10, inhibits TNF-alpha, 
MIP-1alpha, IL-12, and nitric oxide production and 
protects from the lethal effect of endotoxin.
Shock 1998 Jul;10(1):49-53

Zetterstrom M; Lundkvist J; Malinowsky D; Eriksson G; Bartfai T
Interleukin-1-mediated febrile responses in mice and interleukin-1 beta 
activation of NFkappaB in mouse primary astrocytes, 
involves the interleukin-1 receptor accessory protein.
Eur Cytokine Netw 1998 Jun;9(2):131-8

Ehrlich LC; Hu S; Peterson PK; Chao CC
IL-10 down-regulates human microglial IL-8 by inhibition 
of NF-kappaB activation.
Neuroreport 1998 Jun 1;9(8):1723-6

Nakazato Y; Hayashida T; Kanno Y; Sasamura H; and others
Interleukin (IL)-1 and IL-4 synergistically stimulate NF-IL6 activity 
and IL-6 production in human mesangial cells.
Kidney Int 1998 Jul;54(1):71-9

Ruiz-Ortega M; Bustos C; Hernandez-Presa MA; Lorenzo O; and others
Angiotensin II participates in mononuclear cell recruitment in 
experimental immune complex nephritis through nuclear factor-kappa B 
activation and monocyte chemoattractant protein-1 synthesis.
J Immunol 1998 Jul 1;161(1):430-9

Chen G; Kamal M; Hannon R; Warner TD
Regulation of cyclo-oxygenase gene expression 
in rat smooth muscle cells by catalase.
Biochem Pharmacol 1998 May 15;55(10):1621-31

Lentsch AB; Czermak BJ; Bless NM; Ward PA
NF-kappaB activation during IgG immune complex-induced lung injury: 
requirements for TNF-alpha and IL-1beta but not complement.
Am J Pathol 1998 May;152(5):1327-36

Mahboubi K; Young W; Ferreri NR
Tyrosine phosphatase-dependent/tyrosine kinase-independent induction 
of nuclear factor-kappa B by tumor necrosis factor-alpha: 
effects on prostaglandin endoperoxide synthase-2 mRNA accumulation.
J Pharmacol Exp Ther 1998 May;285(2):862-8

Chandrasekar B; Streitman JE; Colston JT; Freeman GL
Inhibition of nuclear factor kappa B attenuates proinflammatory cytokine 
and inducible nitric-oxide synthase expression in postischemic myocardium.
Biochim Biophys Acta 1998 Feb 27;1406(1):91-106

Sakurai H; Shigemori N; Hisada Y; Ishizuka T; and others
Suppression of NF-kappa B and AP-1 activation by glucocorticoids 
in experimental glomerulonephritis in rats: molecular mechanisms 
of anti-nephritic action.
Biochim Biophys Acta 1997 Dec 31;1362(2-3):252-62

Wahl C; Liptay S; Adler G; Schmid RM
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
J Clin Invest 1998 Mar 1;101(5):1163-74

Meldrum DR
Tumor necrosis factor in the heart.
Am J Physiol 1998 Mar;274(3 Pt 2):R577-95

Sempowski GD; Rozenblit J; Smith TJ; Phipps RP
Human orbital fibroblasts are activated through CD40 
to induce proinflammatory cytokine production.
Am J Physiol 1998 Mar;274(3 Pt 1):C707-14

Kikumori T; Kambe F; Nagaya T; Imai T; and others
Activation of transcriptionally active nuclear factor-kappaB 
by tumor necrosis factor-alpha and its inhibition by antioxidants 
in rat thyroid FRTL-5 cells.
Endocrinology 1998 Apr;139(4):1715-22

Carter AB; Monick MM; Hunninghake GW
Lipopolysaccharide-induced NF-kappaB activation and cytokine release in 
human alveolar macrophages is PKC-independent and TK-and PC-PLC-dependent.
Am J Respir Cell Mol Biol 1998 Mar;18(3):384-91

Nakamura T; Goto M; Matsumoto A; Tanaka I
Inhibition of NF-kappa B transcriptional activity 
by alpha-tocopheryl succinate.
Biofactors 1998;7(1-2):21-30

Taglialatela G; Kaufmann JA; Trevino A; Perez-Polo JR
Central nervous system DNA fragmentation induced 
by the inhibition of nuclear factor kappa B.
Neuroreport 1998 Feb 16;9(3):489-93

Sharma SA; Tummuru MK; Blaser MJ; Kerr LD
Activation of IL-8 gene expression by Helicobacter pylori is regulated by 
transcription factor nuclear factor-kappa B in gastric epithelial cells.
J Immunol 1998 Mar 1;160(5):2401-7

Takashiba S; Van Dyke TE; Amar S
Inhibition of nuclear factor kappa B subunit p65 mRNA accumulation 
in lipopolysaccharide-stimulated human monocytic cells treated 
with sodium salicylate.
Oral Microbiol Immunol 1996 Dec;11(6):420-4

Knobil K; Choi AM; Weigand GW; Jacoby DB
Role of oxidants in influenza virus-induced gene expression.
Am J Physiol 1998 Jan;274(1 Pt 1):L134-42

Zhao Q; Simpson LG; Driscoll KE; Leikauf GD
Chemokine regulation of ozone-induced neutrophil and monocyte inflammation.
Am J Physiol 1998 Jan;274(1 Pt 1):L39-46

Aggarwal BB; Higuchi M
Role of ceramide in tumour necrosis factor-mediated apoptosis 
and nuclear factor-kappa B activation.
Biochem Soc Trans 1997 Nov;25(4):1166-71

Srivastava SP; Kumar KU; Kaufman RJ
Phosphorylation of eukaryotic translation initiation factor 2 mediates 
apoptosis in response to activation of the double-stranded RNA-dependent 
protein kinase.
J Biol Chem 1998 Jan 23;273(4):2416-23

Munoz-Fernandez MA; Navarro J; Garcia A; Punzon C; and others
Replication of human immunodeficiency virus-1 in primary human T cells 
is dependent on the autocrine secretion of tumor necrosis factor 
through the control of nuclear factor-kappa B activation.
J Allergy Clin Immunol 1997 Dec;100(6 Pt 1):838-45

De Vera ME; Taylor BS; Wang Q; Shapiro RA; and others
Dexamethasone suppresses iNOS gene expression by upregulating 
I-kappa B alpha and inhibiting NF-kappa B.
Am J Physiol 1997 Dec;273(6 Pt 1):G1290-6

Brigelius-Flohe R; Friedrichs B; Maurer S; Schultz M; Streicher R
Interleukin-1-induced nuclear factor kappa B activation 
is inhibited by overexpression of phospholipid hydroperoxide 
glutathione peroxidase in a human endothelial cell line.
Biochem J 1997 Nov 15;328 ( Pt 1):199-203

Brady TC; Chang LY; Day BJ; Crapo JD
Extracellular superoxide dismutase is upregulated with inducible 
nitric oxide synthase after NF-kappa B activation.
Am J Physiol 1997 Nov;273(5 Pt 1):L1002-6

Okada N; Kobayashi M; Mugikura K; Okamatsu Y; and others
Interleukin-6 production in human fibroblasts derived from periodontal 
tissues is differentially regulated by cytokines and a glucocorticoid.
J Periodontal Res 1997 Oct;32(7):559-69

Driscoll KE; Carter JM; Hassenbein DG; Howard B
Cytokines and particle-induced inflammatory cell recruitment.
Environ Health Perspect 1997 Sep;105 Suppl 5:1159-64

Im SY; Han SJ; Ko HM; Choi JH; and others
Involvement of nuclear factor-kappa B in platelet-activating factor 
mediated tumor necrosis factor-alpha expression.
Eur J Immunol 1997 Nov;27(11):2800-4

Dunn JA; Li C; Ha T; Kao RL; Browder W
Therapeutic modification of nuclear factor kappa B binding activity 
and tumor necrosis factor-alpha gene expression 
during acute biliary pancreatitis.
Am Surg 1997 Dec;63(12):1036-43; discussion 1043-4

Lentsch AB; Shanley TP; Sarma V; Ward PA
In vivo suppression of NF-kappa B and preservation of I kappa B alpha 
by interleukin-10 and interleukin-13.
J Clin Invest 1997 Nov 15;100(10):2443-8

Brand K; Eisele T; Kreusel U; Page M; and others
Dysregulation of monocytic nuclear factor-kappa B 
by oxidized low-density lipoprotein.
Arterioscler Thromb Vasc Biol 1997 Oct;17(10):1901-9

Woronicz JD; Gao X; Cao Z; Rothe M; Goeddel DV
IkappaB kinase-beta: NF-kappaB activation and complex formation 
with IkappaB kinase-alpha and NIK [see comments]
Science 1997 Oct 31;278(5339):866-9
Comment in: Science 1997 Oct 31;278(5339):818-9 

Mercurio F; Zhu H; Murray BW; Shevchenko A; and others
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential 
for NF-kappaB activation [see comments]
Science 1997 Oct 31;278(5339):860-6
Comment in: Science 1997 Oct 31;278(5339):818-9

Shimoyama M; Shimmura S; Tsubota K; Oguchi Y
Suppression of nuclear factor kappa B and CD18-mediated leukocyte 
adhesion to the corneal endothelium by dexamethasone.
Invest Ophthalmol Vis Sci 1997 Oct;38(11):2427-31

Pine R
Convergence of TNFalpha and IFNgamma signalling pathways 
through synergistic induction of IRF-1/ISGF-2 is mediated 
by a composite GAS/kappaB promoter element.
Nucleic Acids Res 1997 Nov 1;25(21):4346-54

Faruqi TR; DiCorleto PE
IFN-gamma inhibits double-stranded RNA-induced E-selectin 
expression in human endothelial cells.
J Immunol 1997 Oct 15;159(8):3989-94

Simeonova PP; Toriumi W; Kommineni C; Erkan M; and others
Molecular regulation of IL-6 activation by asbestos 
in lung epithelial cells: role of reactive oxygen species.
J Immunol 1997 Oct 15;159(8):3921-8

Chao CC; Lokensgard JR; Sheng WS; Hu S; Peterson PK
IL-1-induced iNOS expression in human astrocytes via NF-kappa B.
Neuroreport 1997 Sep 29;8(14):3163-6

Connell P; Young VM; Toborek M; Cohen DA; and others
Zinc attenuates tumor necrosis factor-mediated activation 
of transcription factors in endothelial cells [see comments]
J Am Coll Nutr 1997 Oct;16(5):411-7

Duque N; Gomez-Guerrero C; Egido J
Interaction of IgA with Fc alpha receptors of human mesangial cells 
activates transcription factor nuclear factor-kappa B and induces 
expression and synthesis of monocyte chemoattractant protein-1, 
IL-8, and IFN-inducible protein 10.
J Immunol 1997 Oct 1;159(7):3474-82

Mori N; Prager D
Activation of the interleukin-10 gene in the human T lymphoma line HuT 78: 
identification and characterization of NF-kappa B binding sites 
in the regulatory region of the interleukin-10 gene.
Eur J Haematol 1997 Sep;59(3):162-70

Sato M; Miyazaki T; Kambe F; Maeda K; Seo H
Quercetin, a bioflavonoid, inhibits the induction of interleukin-8 
and monocyte chemoattractant protein-1 expression 
by tumor necrosis factor-alpha in cultured human synovial cells.
J Rheumatol 1997 Sep;24(9):1680-4

Bohrer H; Qiu F; Zimmermann T; Zhang Y; and others
Role of NFkappaB in the mortality of sepsis.
J Clin Invest 1997 Sep 1;100(5):972-85

Erl W; Weber C; Wardemann C; Weber PC
alpha-Tocopheryl succinate inhibits monocytic cell adhesion 
to endothelial cells by suppressing NF-kappa B mobilization.
Am J Physiol 1997 Aug;273(2 Pt 2):H634-40

Bonaiuto C; McDonald PP; Rossi F; Cassatella MA
Activation of nuclear factor-kappa B by beta-amyloid peptides 
and interferon-gamma in murine microglia.
J Neuroimmunol 1997 Jul;77(1):51-6

Bourcier T; Sukhova G; Libby P
The nuclear factor kappa-B signaling pathway participates in dysregulation 
of vascular smooth muscle cells in vitro and in human atherosclerosis.
J Biol Chem 1997 Jun 20;272(25):15817-24

Hattori Y; Nakanishi N; Kasai K
Role of nuclear factor kappa B in cytokine-induced nitric oxide and 
tetrahydrobiopterin synthesis in rat neonatal cardiac myocytes.
J Mol Cell Cardiol 1997 Jun;29(6):1585-92

Kilgore KS; Schmid E; Shanley TP; Flory CM; and others
Sublytic concentrations of the membrane attack complex of complement 
induce endothelial interleukin-8 and monocyte chemoattractant protein-1 
through nuclear factor-kappa B activation.
Am J Pathol 1997 Jun;150(6):2019-31

Neumann FJ; Marx N; Gawaz M; Brand K; and others
Induction of cytokine expression in leukocytes by binding 
of thrombin-stimulated platelets.
Circulation 1997 May 20;95(10):2387-94

Lo CJ; Fu M; Kim B
Macrophage TNF mRNA expression is modulated by protease inhibitors.
J Surg Res 1997 May;69(2):408-12

Brown MC; Tomaras GD; Vincenti MP; Taffet SM
Two forms of NF-kappa B1 (p105/p50) in murine macrophages: differential 
regulation by lipopolysaccharide, interleukin-2, and interferon-gamma.
J Interferon Cytokine Res 1997 May;17(5):295-306

Chapple IL
Reactive oxygen species and antioxidants in inflammatory diseases.
J Clin Periodontol 1997 May;24(5):287-96

Parikh AA; Salzman AL; Kane CD; Fischer JE; Hasselgren PO
IL-6 production in human intestinal epithelial cells 
following stimulation with IL-1 beta is associated 
with activation of the transcription factor NF-kappa B.
J Surg Res 1997 Apr;69(1):139-44

Moriuchi H; Moriuchi M; Fauci AS
Nuclear factor-kappa B potently up-regulates the promoter activity 
of RANTES, a chemokine that blocks HIV infection.
J Immunol 1997 Apr 1;158(7):3483-91

Ebnet K; Brown KD; Siebenlist UK; Simon MM; Shaw S
Borrelia burgdorferi activates nuclear factor-kappa B and is a potent 
inducer of chemokine and adhesion molecule gene expression 
in endothelial cells and fibroblasts.
J Immunol 1997 Apr 1;158(7):3285-92

Lee BS; Kang HS; Pyun KH; Choi I
Roles of tyrosine kinases in the regulation of nitric oxide synthesis in 
murine liver cells: modulation of NF-kappa B activity by tyrosine kinases.
Hepatology 1997 Apr;25(4):913-9

Hernandez-Presa M; Bustos C; Ortego M; Tunon J; and others
Angiotensin-converting enzyme inhibition prevents arterial nuclear 
factor-kappa B activation, monocyte chemoattractant protein-1 expression, 
and macrophage infiltration in a rabbit model of early accelerated 
atherosclerosis.
Circulation 1997 Mar 18;95(6):1532-41

Takagi M; Kasayama S; Yamamoto T; Motomura T; and others
Advanced glycation endproducts stimulate interleukin-6 production 
by human bone-derived cells.
J Bone Miner Res 1997 Mar;12(3):439-46

Bauer MK; Lieb K; Schulze-Osthoff K; Berger M; and others
Expression and regulation of cyclooxygenase-2 in rat microglia.
Eur J Biochem 1997 Feb 1;243(3):726-31

Crofford LJ; Tan B; McCarthy CJ; Hla T
Involvement of nuclear factor kappa B in the regulation of 
cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes.
Arthritis Rheum 1997 Feb;40(2):226-36

Renard P; Zachary MD; Bougelet C; Mirault ME; and others
Effects of antioxidant enzyme modulations on interleukin-1 induced 
nuclear factor kappa B activation.
Biochem Pharmacol 1997 Jan 24;53(2):149-60

Taglialatela G; Robinson R; Perez-Polo JR
Inhibition of nuclear factor kappa B (NFkappaB) activity 
induces nerve growth factor-resistant apoptosis in PC12 cells.
J Neurosci Res 1997 Jan 15;47(2):155-62

Guijarro C; Kim Y; Kasiske BL; Massy ZA; and others
Central role of the transcription factor nuclear factor-kappa B 
in mesangial cell production of chemokines.
Contrib Nephrol 1997;120:210-8

Geng Z; Rong Y; Lau BH
S-allyl cysteine inhibits activation of nuclear factor kappa B 
in human T cells.
Free Radic Biol Med 1997;23(2):345-50

Bonizzi G; Dejardin E; Piret B; Piette J; and others
Interleukin-1 beta induces nuclear factor kappa B in epithelial cells 
independently of the production of reactive oxygen intermediates.
Eur J Biochem 1996 Dec 15;242(3):544-9

de-Mello MA; Flodstrom M; Eizirik DL
Ebselen and cytokine-induced nitric oxide synthase expression 
in insulin producing cells.
Biochem Pharmacol 1996 Dec 13;52(11):1703-9

Harada Y; Watanabe S; Yssel H; Arai K
Factors affecting the cytokine production of human T cells stimulated 
by different modes of activation.
J Allergy Clin Immunol 1996 Dec;98(6 Pt 2):S161-73

Wang CY; Mayo MW; Baldwin AS Jr
TNF and cancer therapy induced apoptosis: potentiation 
by inhibition of NF-kappaB [see comments]
Science 1996 Nov 1;274(5288):784-7 
Comment in: Science 1996 Nov 1;274(5288):724 
Comment in: Science 1997 Apr 11;276(5310):185 

Beg AA; Baltimore D
An essential role for NF-kappaB in preventing TNF-alpha 
induced cell death [see comments] 
Science 1996 Nov 1;274(5288):782-4 
Comment in: Science 1996 Nov 1;274(5288):724 
Comment in: Science 1997 Apr 11;276(5310):185 

Lieb K; Fiebich BL; Schaller H; Berger M; Bauer J
Interleukin-1 beta and tumor necrosis factor-alpha induce 
expression of alpha 1-antichymotrypsin in human astrocytoma 
cells by activation of nuclear factor-kappa B.
J Neurochem 1996 Nov;67(5):2039-44

Hennig B; Toborek M; Mcclain CJ
Antiatherogenic properties of zinc: 
implications in endothelial cell metabolism.
Nutrition 1996 Oct;12(10):711-7

Ramamoorthy L; Kemp MC; Tizard IR
Acemannan, a beta-(1,4)-acetylated mannan, induces nitric 
oxide production in macrophage cell line RAW 264.7.
Mol Pharmacol 1996 Oct;50(4):878-84